Status:
UNKNOWN
Gonadal Changes In Congenital Adrenal Hyperplasia Patients
Lead Sponsor:
Ain Shams University
Conditions:
Congenital Adrenal Hyperplasia
Eligibility:
All Genders
5-16 years
Brief Summary
To detect the prevalence of gonadal changes by US among the patients with CAH. * assess the patients' radiological findings in relation to their hormonal profile. * early management and prevention of...
Detailed Description
Several factors contribute to the impaired fertility in CAH patients, such as androgen excess, adrenal progesterone hypersecretion and adrenal rest tumours (ARTs). ARTs are derived from ectopic adrena...
Eligibility Criteria
Inclusion
- All patients diagnosed with CAH between five and 16 years of age will be asked to participate in this cross sectional study.
- Compliant patients with regular follow up.
Exclusion
- Presence of other endocrinal diseases or chronic conditions.
- Female patients with ovulatory dysfunction from other causes including thyroid dysfunction and hyperprolactinemia.
- Male patients with other diseases causing impairment of gonadal capacity.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04903587
Start Date
October 1 2021
End Date
November 1 2022
Last Update
December 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt